Bank of New York Mellon’s DarioHealth DRIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,354
Closed -$88.8K 4320
2023
Q3
$88.8K Sell
1,354
-27
-2% -$1.82K ﹤0.01% 4098
2023
Q2
$111K Sell
1,381
-7
-0.5% -$532 ﹤0.01% 4072
2023
Q1
$114K Hold
1,388
﹤0.01% 4052
2022
Q4
$119K Sell
1,388
-8
-0.6% -$720 ﹤0.01% 4089
2022
Q3
$129K Buy
+1,396
New +$150K ﹤0.01% 4149
2022
Q2
Sell
-2,166
Closed -$253K 4614
2022
Q1
$253K Sell
2,166
-106
-5% -$17.5K ﹤0.01% 4112
2021
Q4
$589K Buy
2,272
+20
+0.9% +$6.08K ﹤0.01% 3694
2021
Q3
$615K Buy
2,252
+215
+11% +$62K ﹤0.01% 3684
2021
Q2
$870K Buy
+2,037
New +$776K ﹤0.01% 3502

Other funds holding DRIO

Bank of New York Mellon's DRIO Position: Q4 2023 in Review

Bank of New York Mellon sold out of DarioHealth (DRIO) in Q4 2023, closing a stake of 1,354 shares — an estimated $88.8K sold.

Bank of New York Mellon first reported a position in DRIO in Q2 2021 and held it in 9 quarters. The position peaked at $870K in Q2 2021. 35 funds tracked by Wall St. Rank hold DRIO as of Q4 2023.

  • Bank of New York Mellon reported no remaining DarioHealth position as of Q4 2023 after selling out during the quarter.
  • Bank of New York Mellon sold 1,354 DarioHealth shares in Q4 2023, an estimated $88.8K.
  • Bank of New York Mellon first reported a position in DarioHealth in Q2 2021 and held it in 9 quarters.
  • Bank of New York Mellon's DarioHealth position peaked at $870K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held DarioHealth as of Q4 2023.

Based on Bank of New York Mellon's 13F filing for Q4 2023, filed 29 Jan 2024.